Evidence map›Paper›PMID 34733002›Full record

ArticleProceedings (Baylor University. Medical Center)2021

An olfactory neuroblastoma presenting as posterior reversible leukoencephalopathy syndrome.

James J Doyle, Yasmeen Hashimie, Austin Metting

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

James J DoyleDepartment of Internal Medicine, Baylor Scott & White Medical Center - Temple, Temple, Texas.ORCID https://orcid.org/0000-0003-3045-6968
Yasmeen HashimieDepartment of Hematology-Oncology, Baylor Scott & White Medical Center - Temple, Temple, Texas.
Austin MettingDepartment of Internal Medicine, Baylor Scott & White Medical Center - Temple, Temple, Texas.ORCID https://orcid.org/0000-0002-2987-9456
Baylor Scott & White Medical Center - Temple · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Olfactory neuroblastomas are rare malignancies of the nasal and sinus cavities. They have been associated with paraneoplastic syndromes due to secretion of adrenocorticotropin hormone (ACTH) or antidiuretic hormone. These associated paraneoplastic syndromes can present with a wide variety of symptoms that can make diagnosis of the underlying tumor difficult. Here we present the case of a 23-year-old woman who had a seizure due to the development of posterior reversible leukoencephalopathy syndrome because of secondary hypertension due to Cushing's syndrome, which was in turn found to be due to ectopic ACTH production from a metastatic olfactory neuroblastoma.

Indexed as

Adrenocorticotropin hormoneCushing’s syndromeesthesioneuroblastomaolfactory neuroblastomaposterior reversible leukoencephalopathy

Identifiers

PMID34733002
PMCPMC8545063
OpenAlexW3211195337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.